Latest Breaking News On - Acelyrin company profile - Page 3 : comparemela.com

Acelyrin, Inc (NASDAQ:SLRN) CEO Shao-Lee Lin Sells 15,701 Shares

Acelyrin, Inc (NASDAQ:SLRN) CEO Shao-Lee Lin Sells 15,701 Shares
theenterpriseleader.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from theenterpriseleader.com Daily Mail and Mail on Sunday newspapers.

Hidradenitis suppurativaShao lee linOsaic holdings incTower research capitalAcelyrin incAcelyrin company profileWells fargo companyMorgan stanleyJefferies financial groupCapital managementGet free reportLee linTrading downFinancial groupResearch capitalPsoriatic arthritis

Acelyrin, Inc (NASDAQ:SLRN) is CHI Advisors LLC s 5th Largest Position

Acelyrin, Inc (NASDAQ:SLRN) is CHI Advisors LLC s 5th Largest Position
theenterpriseleader.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from theenterpriseleader.com Daily Mail and Mail on Sunday newspapers.

New yorkUnited statesShao lee linHidradenitis suppurativaYork state common retirement fundChi advisorsSecurities exchange commissionWells fargo companyAcelyrin company profileAcelyrin incTower research capitalMorgan stanleyOsaic holdings incJefferies financial groupExchange commissionFree report

Acelyrin (NASDAQ:SLRN) Shares Down 8 6%

Acelyrin, Inc. (NASDAQ:SLRN – Get Free Report)’s stock price fell 8.6% during trading on Tuesday . The company traded as low as $7.62 and last traded at $7.63. 538,704 shares traded hands during trading, a decline of 49% from the average session volume of 1,052,227 shares. The stock had previously closed at $8.35. Wall Street […]

Shao lee linHidradenitis suppurativaJpmorgan chase coWells fargo companyBio partnersAcelyrin incJefferies financial groupVanguard group incMorgan stanleyAcelyrin company profileSecurities exchange commissionAyurmaya capital management companyGet free reportFinancial groupWells fargoTrading down

Acelyrin, Inc (NASDAQ:SLRN) Receives $23 67 Average Target Price from Brokerages

Acelyrin, Inc (NASDAQ:SLRN) Receives $23 67 Average Target Price from Brokerages
theenterpriseleader.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from theenterpriseleader.com Daily Mail and Mail on Sunday newspapers.

Hidradenitis suppurativaShao lee linVanguard group incWells fargo companyJefferies financial groupJpmorgan chase coMorgan stanleyAcelyrin incAyurmaya capital management companyBio partnersAcelyrin company profileGet free reportFinancial groupLee linMaya capital management companyVanguard group

Acelyrin, Inc (NASDAQ:SLRN) Receives Consensus Recommendation of Moderate Buy from Analysts

Acelyrin, Inc. (NASDAQ:SLRN – Get Free Report) has earned an average rating of “Moderate Buy” from the seven analysts that are covering the company, Marketbeat Ratings reports. Three equities research analysts have rated the stock with a hold recommendation and four have issued a buy recommendation on the company. The average twelve-month price target among […]

Shao lee linHidradenitis suppurativaMorgan stanleyAcelyrin incTd asset management incDriehaus capital managementSectoral asset management incWells fargo companyAcelyrin company profileMarshall waceJefferies financial groupGet free reportMarketbeat ratingsFinancial groupWells fargoLee lin